briquilimab
briquilimab: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Jasper Therapeutics Inc. (JSPR) | Phase 2 |
Clinical Trials (1)
Open-Label Extension Study to Evaluate Long Term Safety and Clinical Activity of Briquilimab in Chronic Urticaria
Frequently asked questions
Who is developing briquilimab?
briquilimab is being developed by Jasper Therapeutics Inc..
How many clinical trials involve briquilimab?
BioSniper tracks 1 clinical trial involving briquilimab.
Get deeper analysis on briquilimab
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis